<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01775046</url>
  </required_header>
  <id_info>
    <org_study_id>MDTVCFRANCE001</org_study_id>
    <nct_id>NCT01775046</nct_id>
  </id_info>
  <brief_title>Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases (VALIANT CAPTIVIA France)</brief_title>
  <official_title>Post-market Study on Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Endovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Endovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to assess the benefits of endovascular technique in terms of
      efficacy and safety of Valiant Thoracic Stent Graft with the Captivia Delivery System in the
      treatment of thoracic aortic disease, in a cohort of patients representative of the
      population treated under real-life conditions of use in France for up to 5 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data regarding the use under routine practice of thoracic aortic stent grafts in France are
      expected by the French National Authority for Health (HAS). Therefore, in its opinion report
      from December 22, 2009, HAS makes the maintenance of reimbursement approval of each stent
      graft dependent on the presentation of results of a specific follow-up study carried out in a
      cohort of patients representative of the French population treated under real-life conditions
      of use. This prospective cohort study must involve patients implanted after registration on
      the LPPR (List of Products and Services qualifying for Reimbursement). The results of the
      follow-up study must be forwarded to the National Committee for Evaluation of Medical Devices
      and Health Technologies (CNEDiMTS) for examination once a year. The assessment of this
      follow-up could lead to the recommendation by CNEDiMTS to continue or stop the reimbursement
      of the concerned stent graft.

      In France, The Valiant Thoracic Stent Graft with the Captivia Delivery System is registered
      on the LPPR for a period of 3 years since January 12, 2011. In order to comply with HAS
      expectations, Medtronic Bakken Research Center is setting up this long term
      non-interventional study on the Valiant Thoracic Stent Graft with the Captivia Delivery
      System.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exclusion of aneurysm, penetrating aortic ulcer (PAU), false lumen or rupture site</measure>
    <time_frame>Through 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Events</measure>
    <time_frame>Through 5 years</time_frame>
    <description>This includes respiratory, neurological, vascular, cardiac, renal, bleeding, visceral and infectious complications and any complication leading to death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conversion to open repair</measure>
    <time_frame>Through 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endovascular or surgical secondary procedures</measure>
    <time_frame>Through 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse device effects</measure>
    <time_frame>Through 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thoracic disease-related mortality</measure>
    <time_frame>Through 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">160</enrollment>
  <condition>Aortic Aneurysm, Thoracic</condition>
  <condition>Descending Thoracic Aortic Dissection</condition>
  <condition>Penetrating Ulcer</condition>
  <condition>Aorta Thoracic; Traumatic Rupture</condition>
  <condition>Aortic Diseases</condition>
  <arm_group>
    <arm_group_label>DTA patients</arm_group_label>
    <description>160 patients presenting with a disease of descending thoracic aorta(DTA)with an indication for endovascular treatment with Valiant Thoracic Stent Graft with the Captivia Delivery System and who meet the inclusion/exclusion criteria are intended to participate in this non-interventional.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DTA patients (Valiant)</intervention_name>
    <description>Valiant Thoracic Stent Graft Implantation</description>
    <arm_group_label>DTA patients</arm_group_label>
    <other_name>TEVAR</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects diagnosed with a disease of descending thoracic aorta (DTA) and requiring
        endovascular treatment with Stent Graft.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient requiring placement of the Valiant Thoracic Stent Graft for the treatment
             of a disease of his/her descending thoracic aorta.

          -  Patient or holder of parental authority not opposed to the collection and release of
             the personal information required by the study.

          -  Patient or holder of parental authority has consented for study participation and the
             Medtronic approved Data Release Form has been signed and personally dated by patient
             or holder of parental authority and by the investigator.

        Exclusion Criteria:

          -  Patient in whom clinical follow-up will not be possible i.e. patient not able to come
             back for follow-up visits (ex. patient living abroad).

          -  Prior implantation of a thoracic stent graft.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hervé Rousseau, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rangueil, 1 Avenue Jean Poulhes, TSA 50 032, 31059 TOULOUSE Cedex 9, FRANCE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Amiens Picardie, Hôpital Sud</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux, Groupe Hospitalier Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble, Hôpital A. Michallon</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé de Parly 2</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Chirurgical Marie Lannelongue</name>
      <address>
        <city>Le Plessis-Robinson</city>
        <zip>92350</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique de la Sauvegarde</name>
      <address>
        <city>Lyon</city>
        <zip>69009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé Résidence du Parc</name>
      <address>
        <city>Marseille</city>
        <zip>13010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Saint-Etienne, Hôpital Nord</name>
      <address>
        <city>Saint Priest en Jarez</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Belledonne</name>
      <address>
        <city>Saint-Martin-d'Hères</city>
        <zip>38400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Joseph</name>
      <address>
        <city>Trélazé</city>
        <zip>49800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Tonkin</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69626</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2013</study_first_submitted>
  <study_first_submitted_qc>January 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2013</study_first_posted>
  <last_update_submitted>January 4, 2018</last_update_submitted>
  <last_update_submitted_qc>January 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Valiant</keyword>
  <keyword>Captivia</keyword>
  <keyword>Stent Graft</keyword>
  <keyword>Thoracic</keyword>
  <keyword>Aortic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Aortic Diseases</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

